80_FR_48481 80 FR 48326 - Center for Scientific Review; Notice of Closed Meetings

80 FR 48326 - Center for Scientific Review; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 155 (August 12, 2015)

Page Range48326-48327
FR Document2015-19802

Federal Register, Volume 80 Issue 155 (Wednesday, August 12, 2015) 
[Federal Register Volume 80, Number 155 (Wednesday, August 12, 2015)]
[Notices]
[Pages 48326-48327]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-19802]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Hypertension and Microcirculation.
    Date: September 15, 2015.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Katherine M. Malinda, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 
20892, 301-435-0912, [email protected].

    Name of Committee: Digestive, Kidney and Urological Systems 
Integrated Review Group; Clinical, Integrative and Molecular 
Gastroenterology Study Section.
    Date: September 28, 2015.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 48327]]

    Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military 
Road NW., Washington, DC 20015.
    Contact Person: Mushtaq A. Khan, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2176, MSC 7818, Bethesda, MD 
20892, 301-435-1778, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 7, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-19802 Filed 8-11-15; 8:45 am]
BILLING CODE 4140-01-P

48326 Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices (FDA). The meeting will be open to the 11. RECOTHROM (thrombin, topical FDA is committed to the orderly public. [recombinant]), conduct of its advisory committee Name of Committee: Pediatric 12. PREVNAR 13 (Pneumococcal 13-valent meetings. Please visit our Web site at Conjugate Vaccine [Diphtheria CRM197 http://www.fda.gov/ Advisory Committee. Protein]), General Function of the Committee: 13. PLEXIMMUNE, AdvisoryCommittees/ To provide advice and 14. ELANA SURGICAL KIT (HUD), AboutAdvisoryCommittees/ recommendations to the Agency on 15. BERLIN HEART EXCOR PEDIATRIC ucm111462.htm for procedures on FDA’s regulatory issues. VENTRICULAR ASSIST DEVICE (VAD), public conduct during advisory Date and Time: The meeting will be 16. ENTERRA THERAPY SYSTEM, and committee meetings. held on Wednesday, September 16, 17. CONTEGRA Pulmonary Valved Notice of this meeting is given under 2015, from 8:30 a.m. to 5:30 p.m. Conduit. the Federal Advisory Committee Act (5 Location: Double Tree by Hilton, 8727 FDA intends to make background U.S.C. app. 2). Colesville Rd., Silver Spring, MD 20910, material available to the public no later Dated: August 5, 2015. 301–589–5200. Answers to commonly than 2 business days before the meeting. Jill Hartzler Warner, asked questions including information If FDA is unable to post the background regarding special accommodations due material on its Web site prior to the Associate Commissioner for Special Medical Programs. to a disability, visitor parking, and meeting, the background material will transportation may be accessed at: be made publicly available at the [FR Doc. 2015–19729 Filed 8–11–15; 8:45 am] http://doubletree3.hilton.com/en/hotels/ location of the advisory committee BILLING CODE 4164–01–P maryland/doubletree-by-hilton-hotel- meeting, and the background material washington-dc-silver-spring-DCASSDT/ will be posted on FDA’s Web site after index.html. the meeting. Background material is DEPARTMENT OF HEALTH AND Contact Person: Walter Ellenberg, available at http://www.fda.gov/ HUMAN SERVICES Office of the Commissioner, Food and AdvisoryCommittees/Calendar/ National Institutes of Health Drug Administration, 10903 New default.htm. Scroll down to the Hampshire Ave., Bldg. 32, Rm. 5154, appropriate advisory committee link. Center for Scientific Review; Notice of Silver Spring, MD 20993, 301–796– Procedure: Interested persons may Closed Meetings 0885, email: walter.ellenberg@ present data, information, or views, fda.hhs.gov or FDA Advisory Committee orally or in writing, on issues pending Pursuant to section 10(d) of the Information Line, 1–800–741–8138 before the committee. Written Federal Advisory Committee Act, as (301–443–0572 in the Washington, DC submissions may be made to the contact amended (5 U.S.C. App.), notice is area). A notice in the Federal Register person on or before September 8, 2015. hereby given of the following meetings. about last minute modifications that Oral presentations from the public will The meetings will be closed to the impact a previously announced be scheduled between approximately 9 public in accordance with the advisory committee meeting cannot a.m. and 10 a.m. Those individuals provisions set forth in sections always be published quickly enough to interested in making formal oral 552b(c)(4) and 552b(c)(6), title 5 U.S.C., provide timely notice. Therefore, you presentations should notify the contact as amended. The grant applications and should always check the Agency’s Web person and submit a brief statement of the discussions could disclose site at http://www.fda.gov/ the general nature of the evidence or confidential trade secrets or commercial AdvisoryCommittees/default.htm and arguments they wish to present, the property such as patentable material, scroll down to the appropriate advisory names and addresses of proposed and personal information concerning committee meeting link, or call the participants, and an indication of the individuals associated with the grant advisory committee information line to approximate time requested to make applications, the disclosure of which learn about possible modifications their presentation on or before would constitute a clearly unwarranted before coming to the meeting. September 1, 2015. Time allotted for invasion of personal privacy. Agenda: On September 16, 2015, the each presentation may be limited. If the Pediatric Advisory Committee (PAC) number of registrants requesting to Name of Committee: Center for Scientific will meet to discuss pediatric-focused speak is greater than can be reasonably Review Special Emphasis Panel; accommodated during the scheduled Hypertension and Microcirculation. safety reviews, as mandated by the Best open public hearing session, FDA may Date: September 15, 2015. Pharmaceuticals for Children Act (Pub. Time: 10:00 a.m. to 12:00 p.m. L. 107–109) and the Pediatric Research conduct a lottery to determine the Agenda: To review and evaluate grant Equity Act (Pub. L. 108–155). The PAC speakers for the scheduled open public applications. will meet to discuss the following hearing session. The contact person will Place: National Institutes of Health, 6701 products: notify interested persons regarding their Rockledge Drive, Bethesda, MD 20892, 1. DUREZOL (difluprednate ophthalmic request to speak by September 8, 2015. (Telephone Conference Call). emulsion) 0.05%, Phenylephrine Persons attending FDA’s advisory Contact Person: Katherine M. Malinda, Hydrochloride Ophthalmic Solution, committee meetings are advised that the Ph.D., Scientific Review Officer, Center for 2. ZYLET (loteprednol etabonate and Agency is not responsible for providing Scientific Review, National Institutes of tobramycin ophthalmic suspension), access to electrical outlets. Health, 6701 Rockledge Drive, Room 4140, 3. BETHKIS (tobramycin Inhalation FDA welcomes the attendance of the MSC 7814, Bethesda, MD 20892, 301–435– Solution), 0912, Katherine_Malinda@csr.nih.gov. mstockstill on DSK4VPTVN1PROD with NOTICES public at its advisory committee 4. INTELENCE (etravirine), meetings and will make every effort to Name of Committee: Digestive, Kidney and 5. PREZISTA (darunavir), Urological Systems Integrated Review Group; accommodate persons with physical Clinical, Integrative and Molecular 6. VIRAMUNE XR (nevirapine), 7. EPIDUO (adapalene and benzoyl disabilities or special needs. If you Gastroenterology Study Section. peroxide), require special accommodations due to Date: September 28, 2015. 8. EXJADE (deferasirox), a disability, please contact Walter Time: 8:00 a.m. to 6:00 p.m. 9. DOTAREM (gadoterate meglumine), Ellenberg at least 7 days in advance of Agenda: To review and evaluate grant 10. FYCOMPA (perampanel), the meeting. applications. VerDate Sep<11>2014 18:16 Aug 11, 2015 Jkt 235001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\12AUN1.SGM 12AUN1

Federal Register / Vol. 80, No. 155 / Wednesday, August 12, 2015 / Notices 48327 Place: Embassy Suites at the Chevy Chase Dated: August 7, 2015. Agenda: To review and evaluate grant Pavilion, 4300 Military Road NW., Melanie J. Gray, applications. Washington, DC 20015. Program Analyst, Office of Federal Advisory Place: The Embassy Suites DC Convention Contact Person: Mushtaq A. Khan, Ph.D., Center, 900 10th Street NW., Washington, DC Committee Policy. Scientific Review Officer, Center for 20001. [FR Doc. 2015–19784 Filed 8–11–15; 8:45 am] Contact Person: John Bishop, Ph.D., Scientific Review, National Institutes of BILLING CODE 4140–01–P Scientific Review Officer, Center for Health, 6701 Rockledge Drive, Room 2176, Scientific Review, National Institutes of MSC 7818, Bethesda, MD 20892, 301–435– Health, 6701 Rockledge Drive, Room 5182, 1778, khanm@csr.nih.gov. DEPARTMENT OF HEALTH AND MSC 7844, Bethesda, MD 20892, (301) 408– (Catalogue of Federal Domestic Assistance HUMAN SERVICES 9664, bishopj@csr.nih.gov. Program Nos. 93.306, Comparative Medicine; Name of Committee: Genes, Genomes, and 93.333, Clinical Research; 93.306, 93.333, National Institutes of Health Genetics Integrated Review Group; Molecular 93.337, 93.393–93.396, 93.837–93.844, Genetics B Study Section. 93.846–93.878, 93.892, 93.893, National Center for Scientific Review; Notice of Date: September 28–29, 2015. Institutes of Health, HHS) Closed Meetings Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant Dated: August 7, 2015. Pursuant to section 10(d) of the applications. Anna Snouffer, Federal Advisory Committee Act, as Place: The Westin St. Francis, 335 Powell amended (5 U.S.C. App.), notice is Street, San Francisco, CA 94102. Deputy Director, Office of Federal Advisory hereby given of the following meetings. Contact Person: Richard A Currie, Ph.D., Committee Policy. The meetings will be closed to the Scientific Review Officer, Center for [FR Doc. 2015–19802 Filed 8–11–15; 8:45 am] Scientific Review, National Institutes of public in accordance with the BILLING CODE 4140–01–P provisions set forth in sections Health, 6701 Rockledge Drive, Room 5128, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., MSC 7840, Bethesda, MD 20892, (301) 435– 1219, currieri@csr.nih.gov. as amended. The grant applications and DEPARTMENT OF HEALTH AND the discussions could disclose Name of Committee: Vascular and HUMAN SERVICES Hematology Integrated Review Group; confidential trade secrets or commercial Atherosclerosis and Inflammation of the property such as patentable material, Cardiovascular System Study Section. National Institutes of Health and personal information concerning Date: September 28–29, 2015. individuals associated with the grant Time: 8:00 a.m. to 6:00 p.m. National Institute on Aging; Notice of applications, the disclosure of which Agenda: To review and evaluate grant Closed Meeting would constitute a clearly unwarranted applications. invasion of personal privacy. Place: Bolger Center, 9600 Newbridge Pursuant to section 10(d) of the Drive, Potomac, MD 20854. Federal Advisory Committee Act, as Name of Committee: Vascular and Contact Person: Natalia Komissarova, amended (5 U.S.C. App.), notice is Hematology Integrated Review Group; Ph.D., Scientific Review Officer, Center for Hypertension and Microcirculation Study hereby given of the following meeting. Section. Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5207, The meeting will be closed to the Date: September 14–15, 2015. MSC 7846, Bethesda, MD 20892, 301–435– public in accordance with the Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant 1206, komissar@mail.nih.gov. provisions set forth in sections (Catalogue of Federal Domestic Assistance applications. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: Marriott Wardman Park Washington Program Nos. 93.306, Comparative Medicine; as amended. The grant applications and DC Hotel, 2660 Woodley Road NW., 93.333, Clinical Research, 93.306, 93.333, the discussions could disclose Washington, DC 20008 93.337, 93.393–93.396, 93.837–93.844, confidential trade secrets or commercial Contact Person: Ai-Ping Zou, MD, Ph.D., 93.846–93.878, 93.892, 93.893, National property such as patentable material, Scientific Review Officer, Center for Institutes of Health, HHS) and personal information concerning Scientific Review, National Institutes of Dated: August 6, 2015. individuals associated with the grant Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 20892, 301–408– Carolyn Baum, applications, the disclosure of which 9497, zouai@csr.nih.gov. Program Analyst, Office of Federal Advisory would constitute a clearly unwarranted Committee Policy. Name of Committee: Cardiovascular and invasion of personal privacy. Respiratory Sciences Integrated Review [FR Doc. 2015–19735 Filed 8–11–15; 8:45 am] Name of Committee: National Institute on Group; Lung Injury, Repair, and Remodeling BILLING CODE 4140–01–P Aging Special Emphasis Panel; Male Study Section. Osteoporosis. Date: September 21–22, 2015. Time: 8:00 a.m. to 5:00 p.m. DEPARTMENT OF HEALTH AND Date: September 9, 2015. Agenda: To review and evaluate grant Time: 1:00 p.m. to 4:00 p.m. HUMAN SERVICES applications. Agenda: To review and evaluate grant Place: Embassy Suites at the Chevy Chase applications. National Institutes of Health Pavilion, 4300 Military Road NW., Place: National Institute on Aging, Washington, DC 20015. Gateway Building, Suite 2C212, 7201 Contact Person: Ghenima Dirami, Ph.D., National Cancer Institute; Notice of Wisconsin Ave., Bethesda, MD 20892, Scientific Review Officer, Center for Closed Meetings (Telephone Conference Call). Scientific Review, National Institutes of Pursuant to section 10(d) of the Health, 6701 Rockledge Drive, Room 4122, mstockstill on DSK4VPTVN1PROD with NOTICES Contact Person: Alicja L. Markowska, Federal Advisory Committee Act, as Ph.D., DSC, Scientific Review Branch, MSC 7814, Bethesda, MD 20892, 240–498– 7546, diramig@csr.nih.gov. amended (5 U.S.C. App.), notice is National Institute On Aging, 7201 Wisconsin hereby given of the following meetings. Avenue, Suite 2c212, Bethesda, MD 20892, Name of Committee: Integrative, Functional and Cognitive Neuroscience The meetings will be closed to the 301–496–9666, markowsa@nia.nih.gov. public in accordance with the Integrated Review Group; Sensorimotor (Catalogue of Federal Domestic Assistance Integration Study Section. provisions set forth in sections Program Nos. 93.866, Aging Research, Date: September 22, 2015. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institutes of Health, HHS) Time: 8:00 a.m. to 6:00 p.m. as amended. The grant applications and VerDate Sep<11>2014 18:16 Aug 11, 2015 Jkt 235001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\12AUN1.SGM 12AUN1


Document Created: 2016-09-27 22:27:00
Document Modified: 2016-09-27 22:27:00
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesSeptember 15, 2015.
FR Citation80 FR 48326 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR